•
Simeone AM, Tari AM: How retinoids regulate breast cancer cell proliferation and apoptosis. Cell Mol Life Sci. 2004 Jun;61(12):1475-84. Pubmed•
Formelli F, Cavadini E, Luksch R, Garaventa A, Villani MG, Appierto V, Persiani S: Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide. Cancer Chemother Pharmacol. 2007 Dec 8;. Pubmed•
Takahashi N, Watanabe Y, Maitani Y, Yamauchi T, Higashiyama K, Ohba T: p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action. Int J Cancer. 2008 Feb 1;122(3):689-98. Pubmed• Grubbs, C.J., et al., Anticancer Res. , 10 : 661, (1990).
• Marth, C., et al., J. Natl. Cancer Inst. , 75 : 871, (1985).
• Delia, D., et al., Cancer Res. , 53 : 6036, (1993).
• Delia, D., et al.: Cancer Res., 53, 6036 (1985)
• Costa., A., et al.: Cancer Res., 54, Suppl., 2032s (1985)
• Marth, C., et al.:J. Nat. Cancer Inst., 75, 871 (1985)
• Decensi., A., et al.: Eur. J. Cancer Prev., 3, 377 (1994)
Toxic (T)
